Trial Outcomes & Findings for Exercise Trial in Chronic Kidney Disease (NCT NCT01462097)

NCT ID: NCT01462097

Last Updated: 2023-01-25

Results Overview

VO2peak, measured by Graded Exercise Treadmill Test (GXT) with a modified Balke protocol - higher indicates better aerobic capacity

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

99 participants

Primary outcome timeframe

Baseline, 6 months, 12 months

Results posted on

2023-01-25

Participant Flow

March 2012 through June 2016 recruited from the University of Maryland Medical Center, VA Maryland Healthcare System, Tufts Medical Center, and Partners Healthcare.

Participant milestones

Participant milestones
Measure
Aerobic Exercise
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
Overall Study
STARTED
49
50
Overall Study
6 Month
35
37
Overall Study
COMPLETED
30
38
Overall Study
NOT COMPLETED
19
12

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Exercise Trial in Chronic Kidney Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Aerobic Exercise
n=49 Participants
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=50 Participants
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
Total
n=99 Participants
Total of all reporting groups
Age, Continuous
67.9 years
STANDARD_DEVIATION 7.7 • n=5 Participants
68.1 years
STANDARD_DEVIATION 8.8 • n=7 Participants
68.0 years
STANDARD_DEVIATION 8.2 • n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
10 Participants
n=7 Participants
25 Participants
n=5 Participants
Sex: Female, Male
Male
34 Participants
n=5 Participants
40 Participants
n=7 Participants
74 Participants
n=5 Participants
Race/Ethnicity, Customized
African-American
27 Participants
n=5 Participants
34 Participants
n=7 Participants
61 Participants
n=5 Participants
Race/Ethnicity, Customized
Caucasian
18 Participants
n=5 Participants
13 Participants
n=7 Participants
31 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
Region of Enrollment
United States
49 participants
n=5 Participants
50 participants
n=7 Participants
99 participants
n=5 Participants
Estimated glomerular filtration rate (eGFR)
34.1 ml/min/1.73m^2
STANDARD_DEVIATION 9.5 • n=5 Participants
32.6 ml/min/1.73m^2
STANDARD_DEVIATION 11.4 • n=7 Participants
33.3 ml/min/1.73m^2
STANDARD_DEVIATION 10.5 • n=5 Participants
Hemoglobin (g/dl)
12.5 g/dL
STANDARD_DEVIATION 1.6 • n=5 Participants
12.3 g/dL
STANDARD_DEVIATION 1.7 • n=7 Participants
12.4 g/dL
STANDARD_DEVIATION 1.6 • n=5 Participants
Body Mass Index (kg/m2)
30.3 kg/m2
STANDARD_DEVIATION 7.2 • n=5 Participants
31.8 kg/m2
STANDARD_DEVIATION 5.8 • n=7 Participants
31.1 kg/m2
STANDARD_DEVIATION 6.5 • n=5 Participants
Self-reported Moderate-vigorous physical activity
72 minutes/week
STANDARD_DEVIATION 126 • n=5 Participants
90 minutes/week
STANDARD_DEVIATION 174 • n=7 Participants
78 minutes/week
STANDARD_DEVIATION 150 • n=5 Participants
Coronary Artery Disease
16 Participants
n=5 Participants
13 Participants
n=7 Participants
29 Participants
n=5 Participants
Diabetes
30 Participants
n=5 Participants
28 Participants
n=7 Participants
58 Participants
n=5 Participants
Hypertension
44 Participants
n=5 Participants
48 Participants
n=7 Participants
92 Participants
n=5 Participants
Heart Failure
6 Participants
n=5 Participants
4 Participants
n=7 Participants
10 Participants
n=5 Participants
Peripheral vascular disease
3 Participants
n=5 Participants
6 Participants
n=7 Participants
9 Participants
n=5 Participants
Chronic Obstructive Pulmonary Disease (COPD)
5 Participants
n=5 Participants
8 Participants
n=7 Participants
13 Participants
n=5 Participants
Study Site
Tufts
21 Participants
n=5 Participants
22 Participants
n=7 Participants
43 Participants
n=5 Participants
Study Site
Univ Maryland
28 Participants
n=5 Participants
28 Participants
n=7 Participants
56 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 6 months, 12 months

Population: Participants with complete V02peak at \>=1 time point

VO2peak, measured by Graded Exercise Treadmill Test (GXT) with a modified Balke protocol - higher indicates better aerobic capacity

Outcome measures

Outcome measures
Measure
Aerobic Exercise
n=48 Participants
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=50 Participants
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
Change in Peak Aerobic Capacity
Baseline
17.1 ml/kg/min
Standard Deviation 5.3
16.8 ml/kg/min
Standard Deviation 5.6
Change in Peak Aerobic Capacity
6 months
17.9 ml/kg/min
Standard Deviation 5.5
15.9 ml/kg/min
Standard Deviation 7.0
Change in Peak Aerobic Capacity
12 Months
18.7 ml/kg/min
Standard Deviation 5.2
17.2 ml/kg/min
Standard Deviation 6.4

PRIMARY outcome

Timeframe: Baseline, 6 months, 12 months

Population: Total # with at least one measurement

Distance walked in 6 minutes - greater distance represents higher function

Outcome measures

Outcome measures
Measure
Aerobic Exercise
n=49 Participants
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=50 Participants
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
Change in 6 Minute Walk
Baseline
1298 Feet
Standard Deviation 323
1251 Feet
Standard Deviation 394
Change in 6 Minute Walk
6 months
1649 Feet
Standard Deviation 620
1247 Feet
Standard Deviation 454
Change in 6 Minute Walk
12 months
1453 Feet
Standard Deviation 368
1284 Feet
Standard Deviation 462

SECONDARY outcome

Timeframe: Baseline, 6 months, 12 months

Population: \# of participants with complete measures

Timed Up and Go Test

Outcome measures

Outcome measures
Measure
Aerobic Exercise
n=49 Participants
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=49 Participants
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
Change in Physical Function
Baseline
8.2 Seconds
Standard Deviation 2.4
8.6 Seconds
Standard Deviation 2.7
Change in Physical Function
6 months
8.0 Seconds
Standard Deviation 2.6
9.3 Seconds
Standard Deviation 3.6
Change in Physical Function
12 months
8.3 Seconds
Standard Deviation 29
9.0 Seconds
Standard Deviation 2.9

SECONDARY outcome

Timeframe: Baseline, 6 months, 12 months

Population: \# of participants with complete measures

Short Physical Performance Battery is a test of lower extremity function designed to be administered in older adults, consisting of three components: 1) usual gait speed over a 4-meter course; 2) five repeated chair stands; 3) standing balance battery. Each component is scored 0-4, with higher scores indicating better function, and the total scores of each component are summed (range, 0-12).

Outcome measures

Outcome measures
Measure
Aerobic Exercise
n=49 Participants
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=50 Participants
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
Number With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)
Baseline
19 Participants
19 Participants
Number With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)
6 months
9 Participants
15 Participants
Number With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)
12 months
9 Participants
16 Participants

Adverse Events

Aerobic Exercise

Serious events: 21 serious events
Other events: 30 other events
Deaths: 1 deaths

Health Education

Serious events: 34 serious events
Other events: 31 other events
Deaths: 2 deaths

Serious adverse events

Serious adverse events
Measure
Aerobic Exercise
n=49 participants at risk
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=50 participants at risk
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
General disorders
All SAEs
42.9%
21/49 • Number of events 21 • 12 months or until loss to follow-up or withdrawal.
68.0%
34/50 • Number of events 34 • 12 months or until loss to follow-up or withdrawal.

Other adverse events

Other adverse events
Measure
Aerobic Exercise
n=49 participants at risk
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
Health Education
n=50 participants at risk
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
General disorders
All AEs
61.2%
30/49 • Number of events 66 • 12 months or until loss to follow-up or withdrawal.
62.0%
31/50 • Number of events 79 • 12 months or until loss to follow-up or withdrawal.

Additional Information

Stephen Seliger, MD MS

University of Maryland School of Medicine

Phone: 410-605-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place